Skip to content
10-Q

Quarterly Report

Eloxx Pharmaceuticals, Inc. ELOX

0000950170-23-062940

← back to feed
Filed
Nov 13, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 8, 2023 3.14M sh
Shares Diluted Q3 2023 · Sep 30, 2023 2.75M sh
Shares Diluted Q3 2023 · Sep 30, 2023 2.38M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 2.17M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 2.17M sh
Capex Q3 2023 · Sep 30, 2023 $0
Capex Q3 2023 · Sep 30, 2022 $66K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$12.33M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$26.18M
Long Term Debt Q3 2023 · Sep 30, 2023 $2.62M
Long Term Debt Q3 2023 · Dec 31, 2022 $8.56M
Short Term Debt Q3 2023 · Sep 30, 2023 $2.82M
Short Term Debt Q3 2023 · Dec 31, 2022 $3.98M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $4.78M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $19.21M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $24.55M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$20.05M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$18.6M
Stockholders Equity Q3 2023 · Mar 31, 2023 $16.29M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$10.66M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$4.98M
Stockholders Equity Q3 2023 · Jun 30, 2022 $1.81M
Stockholders Equity Q3 2023 · Mar 31, 2022 $11.69M
Stockholders Equity Q3 2023 · Dec 31, 2021 $22.38M
Current Liabilities Q3 2023 · Sep 30, 2023 $23.47M
Current Liabilities Q3 2023 · Dec 31, 2022 $23.09M
Total Liabilities Q3 2023 · Sep 30, 2023 $26.09M
Total Liabilities Q3 2023 · Dec 31, 2022 $31.78M
Current Assets Q3 2023 · Sep 30, 2023 $5.63M
Current Assets Q3 2023 · Dec 31, 2022 $20.13M
Total Assets Q3 2023 · Sep 30, 2023 $6.04M
Total Assets Q3 2023 · Dec 31, 2022 $21.12M
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.31
Eps Diluted Q3 2023 · Sep 30, 2023 −$5.96
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$3.47
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$13.73
Eps Basic Q3 2023 · Sep 30, 2023 −$1.31
Eps Basic Q3 2023 · Sep 30, 2023 −$5.96
Eps Basic restated Q3 2023 · Sep 30, 2022 −$3.47
Eps Basic restated Q3 2023 · Sep 30, 2022 −$13.73
Sga Expense Q3 2023 · Sep 30, 2023 $2.39M
Sga Expense Q3 2023 · Sep 30, 2023 $6.18M
Sga Expense Q3 2023 · Sep 30, 2022 $2.26M
Sga Expense Q3 2023 · Sep 30, 2022 $7.96M
Net Income Q3 2023 · Sep 30, 2023 −$3.59M
Net Income Q3 2023 · Sep 30, 2023 −$14.16M
Net Income Q3 2023 · Jun 30, 2023 −$4.34M
Net Income Q3 2023 · Mar 31, 2023 −$6.23M
Net Income Q3 2023 · Sep 30, 2022 −$7.51M
Net Income Q3 2023 · Sep 30, 2022 −$29.75M
Net Income Q3 2023 · Jun 30, 2022 −$10.62M
Net Income Q3 2023 · Mar 31, 2022 −$11.62M
Operating Income Q3 2023 · Sep 30, 2023 −$3.64M
Operating Income Q3 2023 · Sep 30, 2023 −$13.26M
Operating Income Q3 2023 · Sep 30, 2022 −$7.14M
Operating Income Q3 2023 · Sep 30, 2022 −$28.39M